Focal scar and diffuse myocardial fibrosis are independent imaging markers in repaired tetralogy of Fallot.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
01 Sep 2019
Historique:
received: 13 11 2018
accepted: 26 03 2019
pubmed: 18 4 2019
medline: 1 12 2020
entrez: 18 4 2019
Statut: ppublish

Résumé

To identify the correlates of focal scar and diffuse fibrosis in patients with history of tetralogy of Fallot (TOF) repair. Consecutive patients with prior TOF repair underwent electrocardiogram, 24-h Holter, transthoracic echocardiography, exercise testing, and cardiac magnetic resonance (CMR) including cine imaging to assess ventricular volumes and ejection fraction, T1 mapping to assess left ventricular (LV) and right ventricular (RV) diffuse fibrosis, and free-breathing late gadolinium-enhanced imaging to quantify scar area at high spatial resolution. Structural imaging data were related to clinical characteristics and functional imaging markers. Cine and T1 mapping results were compared with 40 age- and sex-matched controls. One hundred and three patients were enrolled (age 28 ± 15 years, 36% women), including 36 with prior pulmonary valve replacement (PVR). Compared with controls, TOF showed lower LV ejection fraction (LVEF) and RV ejection fraction (RVEF), and higher RV volume, RV wall thickness, and native T1 and extracellular volume values on both ventricles. In TOF, scar area related to LVEF and RVEF, while LV and RV native T1 related to RV dilatation. On multivariable analysis, scar area and LV native T1 were independent correlates of ventricular arrhythmia, while RVEF was not. Patients with history of PVR showed larger scars on RV outflow tract but shorter LV and RV native T1. Focal scar and biventricular diffuse fibrosis can be characterized on CMR after TOF repair. Scar size relates to systolic dysfunction, and diffuse fibrosis to RV dilatation. Both independently relate to ventricular arrhythmias. The finding of shorter T1 after PVR suggests that diffuse fibrosis may reverse with therapy.

Identifiants

pubmed: 30993335
pii: 5472790
doi: 10.1093/ehjci/jez068
pmc: PMC6704392
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

990-1003

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Lancet. 2000 Sep 16;356(9234):975-81
pubmed: 11041398
J Am Coll Cardiol. 2004 Mar 17;43(6):1068-74
pubmed: 15028368
Radiology. 2005 Dec;237(3):868-71
pubmed: 16304108
Circulation. 2006 Jan 24;113(3):405-13
pubmed: 16432072
Am J Epidemiol. 2007 Mar 15;165(6):710-8
pubmed: 17182981
Circulation. 2007 Jul 31;116(5):545-51
pubmed: 17620511
Circulation. 2009 Apr 7;119(13):1758-67
pubmed: 19307477
Circ Cardiovasc Imaging. 2010 Nov;3(6):727-34
pubmed: 20855860
J Cardiovasc Magn Reson. 2011 Jan 20;13:9
pubmed: 21251297
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):120-5
pubmed: 22235069
Eur J Cardiothorac Surg. 2012 Jul;42(1):e1-8
pubmed: 22561653
J Cardiovasc Magn Reson. 2013 Jul 26;15:64
pubmed: 23890156
Pediatr Radiol. 2014 Apr;44(4):403-9
pubmed: 24419492
Circulation. 2014 Mar 4;129(9):1033-44
pubmed: 24589696
Heart Rhythm. 2014 Oct;11(10):e102-65
pubmed: 24814377
Circulation. 2014 Aug 26;130(9):749-56
pubmed: 24944314
J Cardiovasc Magn Reson. 2014 Oct 01;16:76
pubmed: 25315164
Circulation. 2014 Nov 25;130(22):1944-53
pubmed: 25341442
JACC Cardiovasc Imaging. 2016 Jan;9(1):1-10
pubmed: 26684969
JACC Cardiovasc Imaging. 2016 Jan;9(1):86-7
pubmed: 26684976
Heart. 2016 Feb;102(3):209-15
pubmed: 26715570
Congenit Heart Dis. 2017 Jan;12(1):58-66
pubmed: 27553872
J Cardiovasc Magn Reson. 2016 Oct 26;18(1):75
pubmed: 27782857
Eur Heart J. 2017 Jan 21;38(4):268-276
pubmed: 28182233
Circ Cardiovasc Imaging. 2017 Mar;10(3):
pubmed: 28292861
Am Heart J. 2017 Apr;186:83-90
pubmed: 28454836
Int J Cardiol. 2017 Sep 15;243:191-193
pubmed: 28601469
Eur Radiol. 2018 Jan;28(1):104-114
pubmed: 28677054
Pediatr Cardiol. 2017 Dec;38(8):1569-1574
pubmed: 28776135
J Am Coll Cardiol. 1985 Jul;6(1):221-7
pubmed: 4008776
Circulation. 1995 Jul 15;92(2):158-9
pubmed: 7541319

Auteurs

Hubert Cochet (H)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.
Department of Healthcare Technologies, IHU LIRYC, Université de Bordeaux-Inserm, Avenue du Haut Lévêque, 33604, Pessac, France.

Xavier Iriart (X)

Department of Pediatric and Adult Congenital Cardiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604, Pessac, France.

Antoine Allain-Nicolaï (A)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Claudia Camaioni (C)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Soumaya Sridi (S)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Hubert Nivet (H)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.

Emmanuelle Fournier (E)

Department of Pediatric and Adult Congenital Cardiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604, Pessac, France.

Marie-Lou Dinet (ML)

Department of Pediatric and Adult Congenital Cardiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604, Pessac, France.

Zakaria Jalal (Z)

Department of Pediatric and Adult Congenital Cardiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604, Pessac, France.

Francois Laurent (F)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.
Department of Healthcare Technologies, IHU LIRYC, Université de Bordeaux-Inserm, Avenue du Haut Lévêque, 33604, Pessac, France.

Michel Montaudon (M)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.
Department of Healthcare Technologies, IHU LIRYC, Université de Bordeaux-Inserm, Avenue du Haut Lévêque, 33604, Pessac, France.

Jean-Benoît Thambo (JB)

Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604 Pessac, France.
Department of Pediatric and Adult Congenital Cardiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, Avenue de Magellan, 33604, Pessac, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH